Veterinary Medicines

CRYOMAREX RISPENS

Not authorised
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Download as PDF

Product identification

Medicine name:
CRYOMAREX RISPENS
Cryomarex Rispens, Suspenze a rozpouštědlo pro injekční suspenzi
Active substance:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Target species:
  • Chicken (chick, for replacement)
  • Chicken (broiler)
  • Chicken (for reproduction)
  • Chicken (layer hen)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    10000.00
    plaque forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (chick, for replacement)
      • Meat and offal
        0
        day
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
    • Chicken (layer hen)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken (chick, for replacement)
      • Meat and offal
        0
        day
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
    • Chicken (layer hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Czechia
Package description:
  • 6 ampoules of 2000 doses of frozen suspension and 1 bag of 2.400 ml of diluent
  • 2 ampoules of 2000 doses of frozen suspension and 1 bag of 800 ml of diluent
  • 1 ampoule of 2000 doses of frozen suspension and 1 bag of 400 ml of de diluent
  • 9 ampoules of 1000 doses of frozen suspension and 1 bag of 1.800 ml of diluent
  • 7 ampoules of 1000 doses of frozen suspension and 1 bag of 1.400 ml of diluent
  • 6 ampoules of 1000 doses of frozen suspension and 1 bag of 1.200 ml of diluent
  • 3 ampoules of 1000 doses of frozen suspension and 1 bag of 600 ml of diluent
  • 2 ampoules of 1000 doses of frozen suspension and 1 bag of 400 ml of diluent
  • 1 ampoule of 1000 doses of frozen suspension + 1 bag of 200 ml of diluent

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/051/14-C
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0216/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/04/2023
Download
Czech (PDF)
Published on: 25/10/2022
Download

Package Leaflet

English (PDF)
Published on: 12/04/2023
Download
Czech (PDF)
Published on: 25/10/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
Download